Pharming Group NV (PHAR)
11.77
+0.31
(+2.71%)
USD |
NASDAQ |
Aug 25, 16:00
11.96
+0.19
(+1.61%)
After-Hours: 19:59
Pharming Group Debt to Equity Ratio : 0.4931 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4931 |
| March 31, 2026 | 0.4321 |
| December 31, 2025 | 0.4178 |
| September 30, 2025 | 0.4947 |
| June 30, 2025 | 0.6183 |
| March 31, 2025 | 0.5567 |
| December 31, 2024 | 0.5081 |
| September 30, 2024 | 0.5628 |
| June 30, 2024 | 0.6343 |
| March 31, 2024 | 0.8119 |
| December 31, 2023 | 0.7841 |
| September 30, 2023 | 0.7811 |
| June 30, 2023 | 0.8491 |
| March 31, 2023 | 0.8548 |
| December 31, 2022 | 0.8146 |
| September 30, 2022 | 0.695 |
| June 30, 2022 | 0.7462 |
| March 31, 2022 | 0.8133 |
| December 31, 2021 | 0.8385 |
| September 30, 2021 | 0.8515 |
| June 30, 2021 | 0.8602 |
| March 31, 2021 | 0.8257 |
| December 31, 2020 | 0.8829 |
| September 30, 2020 | 0.9544 |
| June 30, 2020 | 1.010 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.101 |
| December 31, 2019 | 0.4958 |
| September 30, 2019 | 0.6692 |
| June 30, 2019 | 0.8468 |
| March 31, 2019 | 1.035 |
| December 31, 2018 | 1.181 |
| September 30, 2018 | 1.615 |
| June 30, 2018 | 2.054 |
| March 31, 2018 | 2.487 |
| December 31, 2017 | 4.324 |
| September 30, 2017 | 14.24 |
| June 30, 2017 | 13.38 |
| March 31, 2017 | 2.266 |
| December 31, 2016 | 2.454 |
| September 30, 2016 | 1.019 |
| June 30, 2016 | 0.8764 |
| March 31, 2016 | 0.7327 |
| December 31, 2015 | 0.6655 |
| September 30, 2015 | 0.6385 |
| June 30, 2015 | 0.0397 |
| March 31, 2015 | 0.0416 |
| December 31, 2014 | 0.0533 |
| September 30, 2014 | 0.0968 |
| June 30, 2014 | 0.1363 |
| March 31, 2014 | 0.2285 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ProQR Therapeutics NV | 0.166 |
| NewAmsterdam Pharma Co. NV | 0.0001 |
| argenx SE | -- |
| DBV Technologies SA | 0.0784 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 467.98M |
| Total Liabilities (Quarterly) | 210.95M |
| Shareholders Equity (Quarterly) | 257.03M |
| Current Ratio | 3.010 |
| Net Debt Paydown Yield | -0.15% |